Health Sciences Centre Winnipeg

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Stroke3 trials
• Atrial fibrillation1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Ulcerative colitis1 trial

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 41 trial

Status

• Recruiting3 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Janssen Research & Development, LLC1 trial
• Joseph Broderick, MD1 trial
• Pfizer1 trial
• Population Health Research Institute1 trial

Running trials

• Recruiting

  A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  NCT07470879· Phase 2· Pfizer· Source

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Nabiha Faisal (principal investigator)

• Recruiting

  Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

  NCT07227246· Phase 3· Joseph Broderick, MD· Source

  Contact: Nishita Singh, MD, DM, MSc

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

  NCT03968393· Phase 4· Population Health Research Institute· Source

  Contact: Sadeesh Srinathan, MD (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke2 recruiting
• Atrial fibrillation1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Ulcerative colitis1 recruiting